![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 14, Issue 6, 2372-2384, June 2003
* Institute for Medical Biochemistry, University of Muenster, D-48149 Muenster,
Germany;
Institute for Infectiology, University of Muenster, D-48149 Muenster,
Germany; and
Integrated Functional Genomics, University of Muenster, D-48149 Muenster,
Germany
Submitted September 2, 2002;
Revised December 23, 2002;
Accepted February 5, 2003
Monitoring Editor: Anthony P. Bretcher
S100 proteins are EF hand type Ca2+ binding proteins thought to function in stimulus-response coupling by binding to and thereby regulating cellular targets in a Ca2+-dependent manner. To isolate such target(s) of the S100P protein we devised an affinity chromatography approach that selects for S100 protein ligands requiring the biologically active S100 dimer for interaction. Hereby we identify ezrin, a membrane/F-actin cross-linking protein, as a dimer-specific S100P ligand. S100P-ezrin complex formation is Ca2+ dependent and most likely occurs within cells because both proteins colocalize at the plasma membrane after growth factor or Ca2+ ionophore stimulation. The S100P binding site is located in the N-terminal domain of ezrin and is accessible for interaction in dormant ezrin, in which binding sites for F-actin and transmembrane proteins are masked through an association between the N- and C-terminal domains. Interestingly, S100P binding unmasks the F-actin binding site, thereby at least partially activating the ezrin molecule. This identifies S100P as a novel activator of ezrin and indicates that activation of ezrin's cross-linking function can occur directly in response to Ca2+ transients.
Corresponding author. E-mail address:
gerke{at}uni-muenster.de.
This article has been cited by other articles:
|
|
 |
|
  E. Bulk, A. Hascher, R. Liersch, R. M. Mesters, S. Diederichs, B. Sargin, V. Gerke, M. Hotfilder, J. Vormoor, W. E. Berdel, et al. Adjuvant Therapy with Small Hairpin RNA Interference Prevents Non-Small Cell Lung Cancer Metastasis Development in Mice Cancer Res., March 15, 2008; 68(6): 1896 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Whiteman, M. E. Weeks, S. E. Dowen, S. Barry, J. F. Timms, N. R. Lemoine, and T. Crnogorac-Jurcevic The Role of S100P in the Invasion of Pancreatic Cancer Cells Is Mediated through Cytoskeletal Changes and Regulation of Cathepsin D Cancer Res., September 15, 2007; 67(18): 8633 - 8642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tessmer, S. Konig, U. Malkus, R. Reichelt, M. Potter, and A. Steinbuchel Heat-shock protein HspA mimics the function of phasins sensu stricto in recombinant strains of Escherichia coli accumulating polythioesters or polyhydroxyalkanoates Microbiology, February 1, 2007; 153(2): 366 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ohuchida, K. Mizumoto, T. Egami, H. Yamaguchi, K. Fujii, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka S100P Is an Early Developmental Marker of Pancreatic Carcinogenesis. Clin. Cancer Res., September 15, 2006; 12(18): 5411 - 5416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Dowen, T. Crnogorac-Jurcevic, R. Gangeswaran, M. Hansen, J. J. Eloranta, V. Bhakta, T. A. Brentnall, J. Luttges, G. Kloppel, and N. R. Lemoine Expression of S100P and Its Novel Binding Partner S100PBPR in Early Pancreatic Cancer Am. J. Pathol., January 1, 2005; 166(1): 81 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Arumugam, D. M. Simeone, A. M. Schmidt, and C. D. Logsdon S100P Stimulates Cell Proliferation and Survival via Receptor for Activated Glycation End Products (RAGE) J. Biol. Chem., February 13, 2004; 279(7): 5059 - 5065. [Abstract] [Full Text] [PDF]
|
|
